Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950135-03-000627
Filing Date
2003-02-04
Accepted
2003-02-04 14:41:12
Documents
2
Group Members
LIBERTY ACORN TRUSTWAM ACQUISITION GP, INC.

Document Format Files

Seq Description Document Type Size
1 SYNAPTIC PHARMACEUTICAL CORPORATION b45303spsc13gza.txt SC 13G/A 17387
3 JOINT FILING AGREEMENT b45303spexv99w1.txt EX-99.1 1258
  Complete submission text file 0000950135-03-000627.txt   20943
Mailing Address
Business Address 215 COLLEGE RD PARAMUS NJ 07652 2012611331
SYNAPTIC PHARMACEUTICAL CORP (Subject) CIK: 0000884939 (see all company filings)

EIN.: 222859704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45417 | Film No.: 03538287
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 3126349230
LIBERTY WANGER ASSET MANAGEMENT LP (Filed by) CIK: 0000908733 (see all company filings)

EIN.: 363820584 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0000